For antigen-presenting cells like DCs, it was shown in a murine breast cancer model that an anti-CD73 therapy combined with radiotherapy restored conventional DC (cDC) activity and their infiltration into the tumor, enhanced the CD8+/Treg ratio and improved tumor control (Wennerberg et al., 2020). This evidence concerns the gene CD8A and neoplasm.